EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+1.67%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$4.46B
AUM Growth
-$31.4M
(-0.7%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
18.46%
Holding
958
New
11
Increased
191
Reduced
114
Closed
25
Top Buys
| 1 |
Nucor
NUE
|
+$21.2M |
| 2 |
Fluence Energy
FLNC
|
+$11.1M |
| 3 |
Stem
STEM
|
+$9.17M |
| 4 |
Snowflake
SNOW
|
+$7.16M |
| 5 |
Merck
MRK
|
+$6.23M |
Top Sells
| 1 |
Enphase Energy
ENPH
|
+$21.3M |
| 2 |
Target
TGT
|
+$20.8M |
| 3 |
Brookfield Renewable
BEP
|
+$16.4M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$11.8M |
| 5 |
NVIDIA
NVDA
|
+$10.4M |
Sector Composition
| 1 | Technology | 29.44% |
| 2 | Healthcare | 20.57% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Financials | 9.12% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Invesco
IVZ
$9.91B
| $575K | 0.01% |
40,659
+5,919
| +17% | +$83.6K |
|
402
Harmony Biosciences
HRMY
$1.96B
| $572K | 0.01% |
13,100
| – | – |
|
403
Jones Lang LaSalle
JLL
$14.5B
| $570K | 0.01% |
3,835
+583
| +18% | +$86.7K |
|
|
DCBO
404
Docebo
DCBO
$890M
| $566K | 0.01% |
20,900
+2,000
| +11% | +$54.1K |
|
405
EQT Corp
EQT
$31.4B
| $565K | 0.01% |
+14,300
| New | +$565K |
|
406
Crown Holdings
CCK
$11B
| $562K | 0.01% |
+7,000
| New | +$562K |
|
407
Avery Dennison
AVY
$13B
| $556K | 0.01% |
+3,400
| New | +$556K |
|
408
Pacific Biosciences
PACB
$393M
| $552K | 0.01% |
98,500
| – | – |
|
409
Vir Biotechnology
VIR
$728M
| $550K | 0.01% |
28,800
| – | – |
|
410
TSMC
TSM
$1.3T
| $548K | 0.01% |
7,600
-400
| -5% | -$28.9K |
|
411
Humana
HUM
$32.8B
| $543K | 0.01% |
1,105
+91
| +9% | +$44.7K |
|
412
Brown & Brown
BRO
$30.8B
| $542K | 0.01% |
8,900
| – | – |
|
413
Hartford Financial Services
HIG
$36.8B
| $539K | 0.01% |
8,600
| – | – |
|
414
Relay Therapeutics
RLAY
$702M
| $535K | 0.01% |
23,100
| – | – |
|
415
Bright Horizons
BFAM
$6.56B
| $533K | 0.01% |
9,133
+1,400
| +18% | +$81.7K |
|
416
Pacira BioSciences
PCRX
$1.18B
| $532K | 0.01% |
9,800
| – | – |
|
417
Zai Lab
ZLAB
$3.5B
| $530K | 0.01% |
15,100
| – | – |
|
418
Becton Dickinson
BDX
$54.6B
| $525K | 0.01% |
2,321
+191
| +9% | +$43.2K |
|
419
Mondelez International
MDLZ
$81B
| $517K | 0.01% |
9,432
| – | – |
|
420
Chegg
CHGG
$168M
| $515K | 0.01% |
23,808
| – | – |
|
|
RXDX
421
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $506K | 0.01% |
8,800
| – | – |
|
422
BioCryst Pharmaceuticals
BCRX
$1.7B
| $494K | 0.01% |
40,000
| – | – |
|
423
Ocular Therapeutix
OCUL
$2.22B
| $491K | 0.01% |
95,800
| – | – |
|
|
SBNY
424
DELISTED
Signature Bank
SBNY
| $487K | 0.01% |
3,186
+562
| +21% | +$85.9K |
|
425
Principal Financial Group
PFG
$17.8B
| $479K | 0.01% |
6,700
+900
| +16% | +$64.3K |
|